Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro golden dose refers to the 5mg pen used at the halfway point of the licensed titration schedule — a stage many people find is where appetite suppression becomes most noticeable while side effects remain manageable. It is not an official clinical term, but it captures something real about how tirzepatide works over time. These are prescription-only medicines; a GPhC-registered prescriber decides whether your dose is clinically appropriate, and the information below is educational, not personal dosing advice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: your first two pens at 2.5mg are finished. Your prescriber has reviewed your progress and signed off the step up. The 5mg pen arrives, and you're wondering whether anything about how to use the golden dose of Mounjaro is different from the starter pen. The short answer is: the injection process is identical. What shifts is the pharmacological effect.
At 2.5mg, the primary job is settling your system into the medicine, the dual GIP and GLP-1 receptor agonist mechanism is active, but the dose is calibrated for tolerance rather than maximum effect. By 5mg, the golden dose sits in a range that many people describe as the sweet spot: appetite suppression is meaningfully stronger, gastric emptying slows more noticeably, and the gastrointestinal side effects that spiked at 2.5mg have often (though not always) settled down. The NHS tirzepatide page notes that side effects are typically most pronounced when starting or after a dose increase; by 5mg many people are past the worst of the adjustment.
Nothing about the injection itself changes. The pen format, needle size, and the once-weekly schedule stay constant across all Mounjaro strengths. One pen still covers four weekly doses.
A question our prescribers hear most weeks is whether the 5mg pen requires a different technique. It does not. The steps below describe the licensed process as set out in the Patient Information Leaflet; for the exact procedural detail on how to take golden dose Mounjaro, including the number of clicks and the injection-complete signal, always read the leaflet that comes with your pen, it is the clinical authority, not this page.
First, take the pen from the fridge and let it reach room temperature for around 30 minutes; injecting cold medicine can sting. Check the label confirms the correct strength, and inspect the liquid through the viewing window, it should be clear to slightly yellow and free from particles. Wash your hands.
Choose an injection site: the abdomen (at least two inches from the navel), the outer thigh, or the upper arm. Rotate sites each week to avoid skin changes. The volume delivered per dose is fixed by the pen's mechanism, so there is no manual measurement involved.
Remove the base cap, place the pen flat against the skin, press down to unlock, and press and hold the button until the injection is complete and the indicator confirms delivery. Keep the pen pressed for the full count indicated in the leaflet before removing it. Drop the used needle assembly into a sharps container and store the pen back in the fridge between uses.
If a dose is missed, follow the Patient Information Leaflet guidance on the timing window; never double-dose. Your prescriber is the right person to call if you are unsure.
Gastrointestinal symptoms (nausea, looser stools, constipation, reflux, burping) remain the most commonly reported effects as you move through the titration. At 5mg some people experience a brief return of these symptoms, similar to the initial adjustment at 2.5mg, because the body is responding to a higher level of drug activity. For most, this settles within one to two weeks.
Eating smaller portions, slowing down at mealtimes, and staying well hydrated all help the gut adjust. High-fat, high-sugar meals tend to worsen nausea at any dose. If symptoms are severe or persistent, speak to your prescriber before making any changes to your schedule, stopping or adjusting doses without clinical input can affect your progress and safety. You can read more about the side effects associated with altered dosing to understand why unsanctioned changes carry their own risks.
Rare but serious symptoms (severe and persistent stomach pain that radiates to the back, signs of an allergic reaction, or significant dehydration from prolonged vomiting) require urgent medical attention. The MHRA flagged acute pancreatitis as a known, infrequent but serious risk for GLP-1 medicines; report any suspected side effects via the Yellow Card scheme.
The 5mg pen is not a destination, it is a stage. Mounjaro's licensed schedule continues through 7.5mg, 10mg, 12.5mg, and up to 15mg, each increase decided by your prescriber based on your response, tolerability, and clinical assessment. Some people maintain well at 5mg; others move through to higher doses over months. The Mounjaro dosage chart maps the full schedule in a way that is useful for understanding the bigger picture.
If you are still weighing up where tirzepatide fits compared with other options, the weight-loss treatment overview covers the licensed choices in plain terms. And if cost is a practical consideration, the Mounjaro price guide explains what private prescriptions typically include, and what to check for when comparing providers.
When you are ready to take the next step, our prescribers review every consultation the same day it is submitted. Speak to our prescribers through a free consultation at nume and get a clinical view on whether this treatment is right for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.